Entity Details

Primary name UGPA_HUMAN
Entity type UniProt
Source Source Link

Details

AccessionQ16851
EntryNameUGPA_HUMAN
FullNameUTP--glucose-1-phosphate uridylyltransferase
TaxID9606
Evidenceevidence at protein level
Length508
SequenceStatuscomplete
DateCreated1999-07-15
DateModified2021-06-02

Ontological Relatives

GenesUGP2

GO terms

Show/Hide Table
GOName
GO:0003983 UTP:glucose-1-phosphate uridylyltransferase activity
GO:0005634 nucleus
GO:0005737 cytoplasm
GO:0005829 cytosol
GO:0005977 glycogen metabolic process
GO:0005978 glycogen biosynthetic process
GO:0006011 UDP-glucose metabolic process
GO:0006065 UDP-glucuronate biosynthetic process
GO:0007420 brain development
GO:0042802 identical protein binding
GO:0046872 metal ion binding
GO:0070062 extracellular exosome

Subcellular Location

Show/Hide Table
Subcellular Location
Cytoplasm

Domains

Show/Hide Table
DomainNameCategoryType
IPR002618 UDPGP familyFamilyFamily
IPR016267 UTP--glucose-1-phosphate uridylyltransferaseFamilyFamily
IPR029044 Nucleotide-diphospho-sugar transferasesFamilyHomologous superfamily

Diseases

Show/Hide Table
Disease IDSourceNameDescription
618744 OMIMDevelopmental and epileptic encephalopathy 83 (DEE83)A form of epileptic encephalopathy, a heterogeneous group of severe early-onset epilepsies characterized by refractory seizures, neurodevelopmental impairment, and poor prognosis. Development is normal prior to seizure onset, after which cognitive and motor delays become apparent. DEE83 is an autosomal recessive form characterized by onset of frequent, intractable seizures in the first days to months of life. Affected individuals have profound developmental delay with no motor or language skill acquisition, and poor or absent visual tracking. Many patients die in the first years of life. The disease is caused by variants affecting the gene represented in this entry. A recurrent, pathogenic variant affecting the translation initiation codon of isoform 2 has been found in multiple DEE83 families. The variant results in the absence of isoform 2 and leads to reduced levels of functional UGP2 enzyme in neural stem cells. The absence of isoform 2 is compensated by an increased abundance of a functional isoform 1, carrying variant p.Met12Val, which may explain the survival of the patients. A complete absence of functional UGP2 in all cells would be embryonic lethal.